146 related articles for article (PubMed ID: 1982759)
1. Pharmacokinetics of beta-adrenoceptor blocking agents: clinical significance of hepatic and/or renal clearance.
Borchard U
Clin Physiol Biochem; 1990; 8 Suppl 2():28-34. PubMed ID: 1982759
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
Lemmer B
Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
[TBL] [Abstract][Full Text] [Related]
3. Comparison of pharmacokinetic properties of beta-adrenoceptor blocking drugs.
McDevitt DG
Eur Heart J; 1987 Dec; 8 Suppl M():9-14. PubMed ID: 2897304
[TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
Johnsson G; Regàrdh CG
Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic comparison of pindolol with other beta-adrenoceptor-blocking agents.
Meier J
Am Heart J; 1982 Aug; 104(2 Pt 2):364-73. PubMed ID: 6125095
[TBL] [Abstract][Full Text] [Related]
6. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
Mehvar R; Brocks DR
J Pharm Pharm Sci; 2001; 4(2):185-200. PubMed ID: 11466176
[TBL] [Abstract][Full Text] [Related]
7. The effect of six beta-adrenolytics and labetalol on hepatic biotransformation studied by antipyrine test, in man.
Adamska-Dyniewska H; Dziekański S; Pruszczyński J
Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):303-7. PubMed ID: 2874117
[TBL] [Abstract][Full Text] [Related]
8. Consequences of renal insufficiency on the hepatic clearance of some drugs.
Balant LP; Dayer P; Fabre J
Int J Clin Pharmacol Res; 1983; 3(6):459-74. PubMed ID: 6147317
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic models of various beta blockers: an explanation for the long duration of action of bopindolol.
Grevel J
J Cardiovasc Pharmacol; 1986; 8 Suppl 6():S16-9. PubMed ID: 2439812
[TBL] [Abstract][Full Text] [Related]
10. Modulation of effect of dietary salt on prehepatic first-pass metabolism: effects of beta-blockade and intravenous salt loading.
Fromm MF; Darbar D; Dell'Orto S; Roden DM
J Pharmacol Exp Ther; 1999 Jul; 290(1):253-8. PubMed ID: 10381784
[TBL] [Abstract][Full Text] [Related]
11. Beta-adrenoceptor-blocking drugs in the elderly.
Tregaskis BF; McDevitt DG
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S25-8. PubMed ID: 11527132
[TBL] [Abstract][Full Text] [Related]
12. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
Antonaccio MJ; High J; DeForrest JM; Sybertz E
J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of beta-blocking agents pharmacokinetics in obese and non-obese subjects].
Cheymol G
Bull Acad Natl Med; 1990 Oct; 174(7):959-67; discussion 967-8. PubMed ID: 1981983
[TBL] [Abstract][Full Text] [Related]
14. Analysis of hepatic metabolism affecting pharmacokinetics of propranolol in humans.
Kiriyama A; Honbo A; Iga K
Int J Pharm; 2008 Feb; 349(1-2):53-60. PubMed ID: 17765415
[TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. Balanced pharmacokinetics and metabolism of bisoprolol.
Leopold G
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S16-20. PubMed ID: 2439789
[TBL] [Abstract][Full Text] [Related]
17. Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents.
Schneider RE; Bishop H; Kendall MJ; Quarterman CP
Int J Clin Pharmacol Ther Toxicol; 1981 Apr; 19(4):158-62. PubMed ID: 6114930
[TBL] [Abstract][Full Text] [Related]
18. Effect of aging on the pharmcokinetics of atenolol, metoprolol and propranolol in the rat.
Belpaire FM; de Smet F; Vynckier LJ; Vermeulen AM; Rosseel MT; Bogaert MG; Chauvelot-Moachon L
J Pharmacol Exp Ther; 1990 Jul; 254(1):116-22. PubMed ID: 2366179
[TBL] [Abstract][Full Text] [Related]
19. The effects of exercise on the pharmacokinetics of drugs.
Khazaeinia T; Ramsey AA; Tam YK
J Pharm Pharm Sci; 2000; 3(3):292-302. PubMed ID: 11293389
[TBL] [Abstract][Full Text] [Related]
20. The single dose pharmacokinetics of bisoprolol (10 mg) in renal insufficiency: the clinical significance of balanced clearance.
Payton CD; Fox JG; Pauleau NF; Boulton-Jones JM; Ioannides C; Johnston A; Thomas P
Eur Heart J; 1987 Dec; 8 Suppl M():15-22. PubMed ID: 2897297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
